Company
Headquarters: Shanghai, China
CEO: Mr. Duane Lee
TW$1.61 Billion
TWD as of Jan. 1, 2025
US$49.0 Million
| Company | Market Cap (USD) |
|---|---|
| Abbott | $213.72 B |
| Stryker | $150.01 B |
| Boston Scientific Corporation | $149.80 B |
| Medtronic | $114.44 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $47.37 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Cowealth Medical Holding Co., Ltd. operates as a medical distribution company primarily in the diagnostic clinical laboratory field in Greater China market. It also specializes in reagent, cross-strait hospital department cooperation, and radiotherapy fields. In addition, the company undertakes the Summit project, which consolidates outside procurement of diagnostic reagents at prices as before; and provides related with related logistics management services. The company was founded in 1997 and is based in Shanghai, China.
Cowealth Medical Holding Co. Ltd has the following listings and related stock indices.
Stock: TWSE: 4745 wb_incandescent